News

June 24, 2016

Review of Literature About Psoriasis, Sleep Disturbance Inconclusive

News

Researchers conducted a review of literature focused on psoriasis and sleep disturbances. The findings, although inconclusive largely because of scant data concerning prevalence and the nature of sleep disturbances, led researchers to ... Read more

June 22, 2016

Psoriasis Patients Show Higher Presence of Metabolic Syndrome, Study Says

News

Researchers at the Medical University of Lodz accessed the prevalence of metabolic syndrome characteristics in patients with psoriasis, and how such abnormalities affect the disease activity. The findings suggest higher ... Read more

June 21, 2016

Survey of Patients with Psoriasis, Other Diseases, Identifies Knowledge Gaps About Biosimilars

News

Researchers at Pfizer conducted a survey on the knowledge, awareness, and usage of biosimilars among caregivers, patients — including psoriasis patients — and the general population in the U.S. and ... Read more

June 20, 2016

Serious Infections More Prevalent in Inpatients with Psoriasis, Related to Higher Costs and Longer Hospital Stays

News

Researchers at Northwestern University’s Feinberg School of Medicine investigated the rates and predictors of serious infections in hospitalized patients with psoriasis and also quantified the costs of their care, length ... Read more

June 17, 2016

EU Grants Clinical Trial Approval for Plaque Psoriasis Phase 3 Study of ONS-3010 (Humira Biosimilar)

News

Cranbury, New Jersey-based Oncobiologics announced that its Phase 3 clinical strategy for ONS-3010 (Humira biosimilar) has been granted the first of its European Union (EU) clinical trial authorization (CTA) approvals, including Spain, Germany, and ... Read more

June 16, 2016

Can-Fite to Report New Data on Piclidenoson, a Biologic to Treat Psoriasis, at Paris Congress

News

Can-Fite BioPharma, Ltd., announced that its lead drug candidate, Piclidenoson (CF101), has shown similar anti-inflammatory efficacy to the biologics currently on the market for the treatment of psoriasis, with the ... Read more

June 15, 2016

Life Course Approach May Improve Understanding, Management of Psoriasis, Other Chronic Skin Diseases

News

A multi-disciplinary team of researchers conducted a study with the goal of raising the profile of the life course approach, a sociology research tool used in increasing popularity in health research ... Read more

June 14, 2016

Psoriasis Study Finds Cognitive Behavioral Approach Helps Quality of Life, Reduces Disease Severity

News

Researchers recently evaluated the usefulness of psychosocial interventions in patients with psoriasis and found them to be beneficial, improving their quality of life and reducing the disease’s clinical severity. The ... Read more

June 13, 2016June 13, 2016

New Drug to Treat Psoriasis, Ixekizumab, Seen to Aid Almost 80% of Patients in Clinical Trials

News

Three pivotal clinical trials assessing ixekizumab report that the drug is highly effective in treating moderate to severe psoriasis in a majority of patients. The findings, which led to the drug’s approval, are detailed in the study “Phase ... Read more

June 9, 2016

Researchers Find Potential Psoriasis Therapeutic Target in B-Cells and Their Role in Inflammation

News

Researchers focused on B-cells and their possible role in the inflammation characteristic of psoriasis and identified a protein that may constitute a potential therapeutic target to treat the disease. The ... Read more